ERIN STEWART: Open Payments
NPI 1699221333 · FREDERICKSBURG, VA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$989 in 44 payments from 15 companies in 2025. Trend: 2023 $1,400 · 2024 $1,476 · 2025 $989
Food & beverage: $989
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 14 | $283 |
| Novo Nordisk Inc | 8 | $208 |
| Lilly USA, LLC | 5 | $130 |
| Abbott Laboratories | 3 | $70 |
| Exact Sciences Corporation | 2 | $46 |
| PFIZER INC. | 2 | $38 |
| Viatris Specialty LLC | 1 | $31 |
| Otsuka America Pharmaceutical, Inc. | 1 | $29 |
| AstraZeneca Pharmaceuticals LP | 2 | $28 |
| Dexcom, Inc. | 1 | $25 |
Products named: QULIPTA, Ozempic, MOUNJARO, FREESTYLE LIBRE 3, VRAYLAR, UBRELVY, Wegovy, Cologuard Collection Kit.
Industry payments across VA — which companies pay providers there.
